regulatory principles for biosimilar medicines
Published 4 years ago • 72 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
14:19
regulatory pathway for biosimilars
-
8:37
biosimilar medicines: a clinician's perspective
-
4:05
the biosimilar regulatory pathway
-
1:44
fast facts about the regulatory approval pathway for biosimilars – amgen science
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
8:53
biosimilar medicines: a patient's perspective
-
39:16
professor angela thomas: "regulation of biologics & biosimilars"
-
4:53
the value and strategy for incorporating biosimilars into clinical practice
-
59:48
generic drugs and biosimilars 101
-
13:25
biosimilars part 2: regulatory and current status
-
2:47
biosimilars: approval process
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
1:32
the regulation of biosimilars
-
3:35:15
pharmacodynamic biomarkers for biosimilar development and approval: day 1
-
3:11
regulatory efficiency and the 2020 strategy of the generic and biosimilar medicines
-
1:37:27
day2 session 1: perspective on biotherapeutic & biosimilar medicines regulation
-
1:58
fda review and approval process for biosimilar medications
-
19:39
02 the us biosimilars regulatory pathway
-
3:42:11
pharmacodynamic biomarkers for biosimilar development and approval: day 2